Skip To Main Content
Jian Hang Lam on Muck Rack

Jian Hang Lam

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jian Hang

Contact Jian Hang, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery

|
By Jian Hang Lam, Gaurav Sinsinbar, Yan Lee, Jing Fong
| dx.doi.org
Open in Who Shared Issue with article?

A Novel Polymersome Nanocarrier Promotes Anti‐Tumour Immunity by Improved Priming of CD8 + T Cells

|
By William Ho, Victor Ho Verified, Jian Hang Lam, Fabien M. Décaillot
| Wiley Online Library Verified
1 Introduction Despite major advances in modern medicine, cancer is a leading cause of death among humans worldwide. Depending on the type of cancer, the stage or rate of tumour progression, disease severity and prognosis drastically vary, determining quality of life and survival chances of each individual patient.
Open in Who Shared Issue with article?

Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future Drug Product Development

|
By Gaurav Sinsinbar, Anivind Kaur Bindra, Shaoqiong Liu, Jian Hang Lam
| dx.doi.org
Nanoformulation of active payloads or pharmaceutical ingredients (APIs) has always been an area of interest to achieve targeted, sustained, and efficacious delivery. Various delivery platforms have been explored, but loading and delivery of APIs have been challenging because of the chemical and structural properties of these molecules.
Open in Who Shared Issue with article?
See all 3 articles